Comparative Analysis of the Consumption of Drugs for the Treatment of Coronavirus Sars-Cov2 in the Hospitals of Castilla y León

  • Funded by Junta de Castilla y Leon - Consejeria de Sanidad
  • Total publications:3 publications

Grant number: GRS COVID 10/A/20

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $6,528.65
  • Funder

    Junta de Castilla y Leon - Consejeria de Sanidad
  • Principal Investigator

    Francisco Magno Herrera Gómez
  • Research Location

    Spain
  • Lead Research Institution

    Complejo Asistencial De Zamora
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival.

A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death.

Clinical Profile, Treatment and Predictors during the First COVID-19 Wave: A Population-Based Registry Analysis from Castile and Leon Hospitals.